Abstract
Introduction: Axial involvement occurs in 25%-70% of patients with PsA. Here we report pooled axial-related efficacy results from the GUS DISCOVER-1 and DISCOVER-2 studies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
